Author: Customer Service
ATHENS, Greece, Dec. 20, 2024 (GLOBE NEWSWIRE) — Diana Shipping Inc. (NYSE: DSX), (the “Company”), a global shipping company specializing in the ownership and bareboat charter-in of dry bulk vessels, today announced that, through a separate wholly-owned subsidiary, it has entered into a time charter contract with Nippon Yusen Kabushiki Kaisha, Tokyo, for one of its Kamsarmax dry bulk vessels, the m/v Myrto. The gross charter rate is US$12,000 per day, minus a 5.00% commission paid to third parties, for a period until minimum March 1, 2026 up to maximum May 15, 2026. The charter is expected to commence on December 23, 2024.
The “Myrto” is an 82,131 dwt Kamsarmax dry bulk vessel built in 2013.
The employment of “Myrto” is anticipated to generate approximately US$5.11 million of gross revenue for the minimum scheduled period of the...
OceanPal Inc. Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2024
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
ATHENS, Greece, Dec. 20, 2024 (GLOBE NEWSWIRE) — OceanPal Inc. (NASDAQ: OP) (the “Company”), a global shipping company specializing in the ownership of vessels, today reported vessel revenues of $7.5 million, a net loss of $0.2 million and net loss attributed to common stockholders of $0.6 million for the third quarter of 2024. This compares to vessel revenues of $3.9 million, a net loss of $3.4 million and net loss attributed to common stockholders of $3.9 million for the third quarter of 2023.
For the nine months ended September 30, 2024, the Company reported vessel revenues of $19.9 million, a net loss of $9.7 million and net loss attributed to common stockholders of $10.9 million. This compares to vessel revenues of $13.1 million, a net loss of $2.0 million and net loss attributed to common stockholders of $3.9 million for...
Ferrellgas Partners, L.P. Reports First Quarter Fiscal Year 2025 Results
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
LIBERTY, Mo., Dec. 20, 2024 (GLOBE NEWSWIRE) — Ferrellgas Partners, L.P. (OTC: FGPR) (“Ferrellgas” or the “Company”) today reported financial results for its 2025 first fiscal quarter ended October 31, 2024.
In sharing 2025 fiscal first quarter results, Tamria Zertuche, President and Chief Executive Officer, commented, “The employee-owners of Ferrellgas have delivered another solid quarter. Executing on our strategy of targeted customer growth, operational excellence, consolidation, and safety, we have gained the right momentum heading into the Retail heating season while maintaining consistent volume increases within our branded Blue Rhino tank exchange operations. The first quarter of the fiscal year has historically included the navigation of storm events, and this quarter was no different. Our highly tenured, experienced workforce...
Digital Marketing Agency Moburst Acquires Uproar PR
Written by Customer Service on . Posted in Mergers And Acquisitions.
The move adds media relations to Moburst’s service offerings for clients and expands the company’s U.S presence
NEW YORK, Dec. 20, 2024 (GLOBE NEWSWIRE) — Moburst, the leading mobile-first digital marketing agency, today announces its acquisition of Uproar PR, an award-winning public relations firm. This strategic move strengthens Moburst’s capabilities, offering a more comprehensive suite of services to its clients worldwide.
Founded in 2011, Uproar specializes in providing PR services to clients in a wide range of industries, including technology, consumer products, lifestyle and healthcare. The firm focuses on finding each client’s unique story and securing earned media coverage that moves the needle – whether it’s lead generation, helping drive sales or brand building. Uproar routinely lands clients in national...
Woodward Signs Agreement to Acquire Safran’s Electromechanical Actuation Business Based in North America
Written by Customer Service on . Posted in Mergers And Acquisitions.
~Acquisition provides Woodward industry-proven electromechanical technology platform for next generation aircraft. It is a step forward for Safran towards the acquisition of Collins Aerospace actuation and flight control activities~
FORT COLLINS, Colo. and PARIS, Dec. 20, 2024 (GLOBE NEWSWIRE) — Woodward (NASDAQ: WWD), a global leader in aerospace and industrial energy control solutions, announced today that it has signed a definitive agreement to acquire the Safran Electronics & Defense electromechanical actuation business based in the United States, Mexico and Canada. The acquisition includes intellectual property, operations assets, talent, and long-term customer agreements for Horizontal Stabilizer Trim Actuation (HSTA) systems for aircraft stabilization to support safe and efficient flight, notably used for the Airbus...
Prosper Gold Corp. Closes Second Tranche of Private Placement
Written by Customer Service on . Posted in Public Companies.
VANCOUVER, British Columbia, Dec. 20, 2024 (GLOBE NEWSWIRE) — Prosper Gold Corp. (“Prosper Gold” or the “Company“) (TSXV: PGX) announces that it has closed the second tranche of a private placement financing of common shares in the capital of the Company that qualify as “flow-through shares” for the purposes of the Income Tax Act (Canada) (each, a “FT Share”). The second tranche of the financing consisted of 1,818,182 FT Shares at a price of $0.11 per FT Share, for gross proceeds to the Company of $200,000 (the “Second Tranche”).
In connection with the Second Tranche, the Company paid $14,000 in cash and issued 127,272 common share purchase warrants (each, a “Broker Warrant“) to finders at closing. Each Broker Warrant is non-transferable and exercisable for one common share in the capital of...
Alignment Healthcare to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Written by Customer Service on . Posted in Public Companies.
ORANGE, Calif. , Dec. 20, 2024 (GLOBE NEWSWIRE) — Alignment Healthcare, Inc. (NASDAQ: ALHC), today announced that it will present at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, Jan. 15, at 1:30 p.m. PST.
A webcast and replay of the presentations will be available on Alignment’s investor relations website at https://ir.alignmenthealth.com/.
About Alignment HealthcareAlignment Health is championing a new path in senior care that empowers members to age well and live their most vibrant lives. A consumer brand name of Alignment Healthcare (NASDAQ: ALHC), Alignment Health’s mission-focused team makes high-quality, low-cost care a reality for its Medicare Advantage members every day. Based in California, the company partners with nationally recognized and trusted local providers to deliver coordinated...
Stantec announces appointments of Christopher Lopez and Rick Eng to the Board of Directors
Written by Customer Service on . Posted in Public Companies.
EDMONTON, Alberta, Dec. 20, 2024 (GLOBE NEWSWIRE) — TSX, NYSE: STN
Stantec Inc. (“Stantec”), a global leader in sustainable design and engineering, announced today the appointments of Christopher Lopez and Richard (Rick) Eng to the company’s Board of Directors, effective January 1, 2025.
Christopher Lopez has over 28 years of industry experience in the utility, power generation, and mining sectors in Canada, United States, Mexico, Australia and New Zealand. Mr. Lopez has served in various senior leadership positions including, most recently, as Chief Financial and Regulatory Officer at Hydro One Limited. In addition to his strong financial and regulatory acumen, Mr. Lopez has significant experience in mergers and acquisitions and clean energy finance from both his time at Hydro One and, prior to that, as Vice President, Corporate...
Apollomics Announces Top-line Results for Phase 3 Bridging Trial of Uproleselan in China in Patients with Relapsed or Refractory Acute Myeloid Leukemia
Written by Customer Service on . Posted in Public Companies.
FOSTER CITY, Calif., Dec. 20, 2024 (GLOBE NEWSWIRE) — Apollomics Inc. (Nasdaq: APLM) (“Apollomics” or the “Company”), a late-stage clinical biopharmaceutical company developing multiple oncology drug candidates to address difficult-to-treat and treatment-resistant cancers, announced today the results from its Phase 3 bridging trial of uproleselan in China in patients with relapsed or refractory acute myeloid leukemia. The trial did not demonstrate favorable benefit for uproleselan.
The Phase 3 trial was a randomized, double-blinded bridging trial to evaluate the safety and efficacy of uproleselan administered with chemotherapy versus chemotherapy alone in patients with relapsed or refractory acute myeloid leukemia. The primary endpoint was comparing overall survival (OS) in the uproleselan treatment arm versus the control arm....
RAD 202 Receives Approval to Start Phase 1 Therapeutic Trial
Written by Customer Service on . Posted in Public Companies.
Ethics approval received in Australia for the initiation of RAD’s Phase 1 therapeutic trial of 177Lu-RAD202 in Breast and Gastric Cancers
The Phase 1 First-In-Human study is designed to assess the safety, tolerability & preliminary clinical activity of 177Lu-RAD202 in individuals with HER2-positive metastatic solid tumors
Ten HER2-positive breast cancer patients previously dosed in a Phase 1 diagnostic study demonstrated the safety and biodistribution of 177Lu-RAD202, validating its potential for the treatment of advanced HER2-expressing cancersSYDNEY, Dec. 20, 2024 (GLOBE NEWSWIRE) — Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical need, is pleased to announce it has...